We previously demonstrated that heterozygous deletion of Gabra1, the mouse homolog of the human absence epilepsy gene that encodes the GABA A receptor (GABA A R) α1 subunit, causes absence seizures. We showed that cortex partially compensates for this deletion by increasing the cell surface expression of residual α1 subunit and by increasing α3 subunit expression. Absence seizures also involve two thalamic nuclei: the ventrobasal (VB) nucleus, which expresses only the α1 and α4 subtypes of GABA A R α subunits, and the reticular (nRT) nucleus, which expresses only the α3 subunit subtype. Here, we found that, unlike cortex, VB exhibited significantly reduced total and synaptic α1 subunit expression. In addition, heterozygous α1 subunit deletion substantially reduced miniature inhibitory postsynaptic current (mIPSC) peak amplitudes and frequency in VB. However, there was no change in the expression of the extrasynaptic α4 or δ subunits in VB and, unlike other models of absence epilepsy, no change in tonic GABA A R currents. Although heterozygous α1 subunit knockout increased α3 subunit expression in medial thalamic nuclei, it did not alter α3 subunit expression in nRT. However, it did enlarge the presynaptic vesicular inhibitory amino acid transporter puncta and lengthen the time constant of mIPSC decay in nRT. We conclude that increased tonic GABA A currents are not necessary for absence seizures. In addition, heterozygous loss of α1 subunit disinhibits VB by substantially reducing phasic GABAergic currents and surprisingly, it also increases nRT inhibition by prolonging phasic currents. The increased inhibition in nRT likely represents a partial compensation that helps reduce absence seizures.
Introduction
Epilepsy is a disorder in which the brain exhibits an enduring predisposition to generate seizures. It is a common disease that affects approximately 1% of the population and resists optimal medical therapy in approximately one third of cases. Typical absence seizures are a common seizure type that cause brief interruptions of consciousness and are associated with rhythmic 3 Hz bi-hemispheric spike-andwave discharges on EEG. They occur in several different genetic generalized epilepsy (GGE) syndromes including childhood absence epilepsy (CAE), juvenile absence epilepsy, and juvenile myoclonic epilepsy. Although anticonvulsant medications are often effective in reducing absence seizures, approximately 50% of CAE patients fail optimal medical management (Glauser et al., 2013) and thus are at risk for injury as well as memory and behavioral deficits (Kernan et al., 2012; Lin et al., 2013) .
Studies of rodent models of absence seizures suggested that typical absence seizures start in layer VI of the somatosensory cortex and quickly spread to the remainder of the cortex and two thalamic nuclei, the ventrobasal (VB) and reticular (nRT) nuclei (Meeren et al., 2002; Polack et al., 2007) . Although the VB and nRT nuclei do not initiate the epileptic discharges in these models, unilateral VB/nRT lesions abolish absence seizures in rodents, a result that emphasizes the importance of these nuclei in seizure generation (Meeren et al., 2009 ). The cortex, VB, nRT, and interconnections among these regions comprise the thalamocortical network that is thought to be the core network involved in absence seizures.
Recent studies revealed that different pharmacological and genetic absence epilepsy models possess defects in different components of the thalamocortical network (Cope et al., 2009; Tan et al., 2007; Paz et al., 2011; Errington et al., 2011) . Understanding the aberrant neurophysiology in different models of absence epilepsy will lead to the development of new pharmacological and, possibly, neurostimulation therapies for medically intractable absence seizures. 
